Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period
- PMID: 9892267
- DOI: 10.1097/00000441-199901000-00003
Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period
Abstract
Hypotension during hemodialysis in end-stage renal disease (ESRD) not explained by excessive ultrafiltration has been linked to an apparent increase in the synthesis of nitric oxide (NO). The authors tested whether the induction of NO synthase (iNOS) by cytokines or differences in the concentrations of inhibitors of NOS or both could account for variability in the amount of NO synthesized during hemodialysis. Plasma levels of an inhibitor of NOS, asymmetric dimethylarginine (ADMA), L-arginine, the substrate for NOS, the end-products N02+N03, iNOS activity in circulating buffy coat cells, and their interdialytic changes were measured in 10 patients during three treatments. Predialysis (0') levels of ADMA were markedly elevated with a mean of 0.008+/-0.002 micromol/mL of deproteinized plasma, compared to controls where ADMA is present in trace amounts. ADMA levels from 30 minutes to the end of dialysis correlated directly with the drop in blood pressure (BP), with levels being much higher in patients with severe hypotension. Postdialysis ADMA levels correlated directly with the 0' systolic BP and the drop in BP at the next dialysis treatment. NOS activity was detected in two thirds of the predialysis buffy coat samples, and appeared to increase as dialysis progressed. 0' iNOS activity correlated inversely with the 0' BP, but activities did not differ based on percent drop in BP. iNOS activity in the 0' samples correlated inversely with the time since the last dialysis, reflecting the greater accumulation of dialyzable inhibitors of NOS as the interval is prolonged. The interdialytic change in iNOS activity correlated inversely with the drop in BP. The isoform detected immunochemically in the buffy coat samples had an Mr of 130 kDa and was reactive with antihuman iNOS. Thus, iNOS is already induced in the cells of the buffy coat in many intermittently hemodialyzed ESRD subjects, but its expression may be masked by inhibitors. After 60 minutes of dialysis (too brief a time for the de novo induction of iNOS,) the appearance of or increase in iNOS activity suggests that an inhibitor had been removed. Because ADMA levels are associated with higher predialysis systolic BPs that result in a greater severity of hypotension, reduction in ADMA concentrations would appear to play a major role in the resumption of NO synthesis by various isoforms.
Similar articles
-
Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.Am J Med Sci. 2001 Feb;321(2):113-23. doi: 10.1097/00000441-200102000-00002. Am J Med Sci. 2001. PMID: 11217813
-
Response of asymmetric dimethylarginine to hemodialysis-associated hypotension in end-stage renal disease patients.Nephron Clin Pract. 2008;108(2):c127-34. doi: 10.1159/000114451. Epub 2008 Jan 30. Nephron Clin Pract. 2008. PMID: 18230915
-
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.J Am Soc Nephrol. 1999 Mar;10(3):594-600. doi: 10.1681/ASN.V103594. J Am Soc Nephrol. 1999. PMID: 10073610 Clinical Trial.
-
Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease.Kidney Int Suppl. 2001 Feb;78:S9-13. doi: 10.1046/j.1523-1755.2001.59780009.x. Kidney Int Suppl. 2001. PMID: 11168975 Review.
-
Implications for the role of endogenous nitric oxide inhibitors in hemodialysis hypotension.Free Radic Res. 2001 Oct;35(4):341-65. doi: 10.1080/10715760100300871. Free Radic Res. 2001. PMID: 11697132 Review.
Cited by
-
Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review.Am J Nephrol. 2008;28(2):224-37. doi: 10.1159/000110092. Epub 2007 Oct 24. Am J Nephrol. 2008. PMID: 17960061 Free PMC article.
-
Doppler ultrasound evaluation of morphological and hemodynamical changes of hepatic and mesenteric structures in end-stage renal disease patients on regular hemodialysis.Int Urol Nephrol. 2010 Mar;42(1):205-10. doi: 10.1007/s11255-009-9617-y. Epub 2009 Jul 24. Int Urol Nephrol. 2010. PMID: 19629742
-
The Influence of Sevelamer Hydrochloride and Calcium Carbonate on Markers of Inflammation and Oxidative Stress in Hemodialysis at Six Months of Follow-Up.Front Med (Lausanne). 2021 Nov 25;8:714205. doi: 10.3389/fmed.2021.714205. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34901050 Free PMC article.
-
Effect of haemodialysis on retinal circulation in patients with end stage renal disease.Br J Ophthalmol. 2004 Aug;88(8):1026-9. doi: 10.1136/bjo.2003.039073. Br J Ophthalmol. 2004. PMID: 15258019 Free PMC article.
-
Interaction of Human Serum Albumin with Uremic Toxins: The Need of New Strategies Aiming at Uremic Toxins Removal.Membranes (Basel). 2022 Feb 25;12(3):261. doi: 10.3390/membranes12030261. Membranes (Basel). 2022. PMID: 35323736 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical